CLEMENTIA PHARMACEUTICALS IN - COM (CMTA)

CUSIP: 185575107

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM
Total 13F shares
28,040,063
Share change
-1,912,693
Total reported value
$731,842,050
Price per share
$26.10
Number of holders
48
Value change
+$5,024,134
Number of buys
35
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 185575107?
CUSIP 185575107 identifies CMTA - CLEMENTIA PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLEMENTIA PHARMACEUTICALS IN - COM (CMTA) as of Q1 2019

As of 31 Mar 2019, CLEMENTIA PHARMACEUTICALS IN - COM (CMTA) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,040,063 shares. The largest 10 holders included ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, NEA Management Company, LLC, JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, Kite Lake Capital Management (UK) LLP, WELLINGTON MANAGEMENT GROUP LLP, Alyeska Investment Group, L.P., Tudor Investment Corp Et Al, and DRIEHAUS CAPITAL MANAGEMENT LLC. This page lists 48 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.